Latest News

After learning she had breast cancer, Patricia Latham agreed to take part in a clinical trial to assess whether some women could avoid radiation.

People with Alzheimer's tend to be less likely to get cancer. Could whatever is happening biologically be harnessed to recharge the immune system?

Treatments for Ewing sarcoma have been essentially the same 30 years. Dr. Casey Langdon wants to change that.

A new clinical trial for women with recurrent ovarian cancer is an outgrowth of a long-term partnership between a researcher, a donor and physicians.

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC students receive world-class training and make worldwide connections at an international redox training program in Hungary.